Medication info
Albogen Cimetidine Tablet 200 Milligrams

Albogen Cimetidine Tablet 200 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›400mg / 1 tablet
Manufacturer / importer
Albogen Korea Co., Ltd.
Appearance
Pale yellow round film-coated tablet
Packaging
300 tablets/bottle
Approval status
Active

MFDS item code 201307160 · Approved 2013.05.01 · Insurance code 652606940

Summary

Main use
Treatment of ulcers, reflux esophagitis, and Zollinger-Ellison syndrome; improvement of gastric mucosal lesions in gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in this case, increase the frequency of administration rather than the amount per dose. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, 12 hours apart. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, 8 hours apart, or more frequently, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Albogen Korea Co., Ltd.

Efficacy & effects

Treatment of ulcers, reflux esophagitis, and Zollinger-Ellison syndrome; improvement of gastric mucosal lesions in gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • edema
  • acute gastritis
View approved original text

This medication is used for various gastrointestinal disorders including gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcer, anastomotic ulcer, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal lesions such as erosion, bleeding, redness, and edema that occur during acute exacerbation of acute and chronic gastritis. Therefore, it is used as an effective treatment to protect the gastric mucosa, alleviate inflammation, and improve symptoms.

How to take

Adult dose

Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime; total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg per dose twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in this case, increase the frequency of administration rather than the amount per dose. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine per dose twice daily, 12 hours apart. If necessary, depending on the patient's symptoms, the frequency may be increased to 3 times daily, 8 hours apart, or more frequently, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers the blood cimetidine concentration. After hemodialysis, administer the medicine again according to the schedule. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children: Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This medication contains the ingredient cimetidine and should not be used by patients with specific allergic reactions or those taking another medication called dofetilide. Patients with lactose intolerance or genetic lactose metabolism disorders should also avoid this medication. Patients with kidney or liver function problems, those with a history of drug allergies, the elderly, children, and those undergoing hemodialysis should use this medication cautiously. This medication may hide symptoms of gastric cancer, so it should only be used after confirming malignancy, and patients with Helicobacter pylori infection require eradication treatment. Patients allergic to Yellow No. 4 (tartrazine) should also be careful. Rarely, adverse symptoms such as decreased blood cell counts, liver function abnormalities, kidney dysfunction, allergic reactions, gynecomastia, gastrointestinal symptoms, neurological symptoms, etc., may occur, and if any unusual symptoms arise, immediate consultation with a doctor is needed. The minimum effective dose should be used, and if ineffective, it is best to switch to another treatment method. The risk of pneumonia may increase in the elderly or those with chronic diseases, so caution is advised. It may interact with other drugs, so especially when combined with anticoagulants, antidepressants, antiarrhythmics, calcium channel blockers, antifungal agents, etc., follow the doctor's instructions. Women who are pregnant or breastfeeding should use this medication cautiously as its safety has not been established, and breastfeeding should be discontinued during its use. Overdose may lead to severe symptoms such as respiratory depression, and immediate medical attention should be sought, and intravenous administration should be given slowly to minimize side effects. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Leukopenia
  • agranulocytosis
  • aplastic anemia
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • systemic fatigue
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
Show 51 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
  • elevated ALT
  • impaired liver function
  • perivascular liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactic-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • galactorrhea
  • increased vaginal discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • convulsions
  • limb numbness
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusion
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema edema
  • fatigue
  • systemic warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the medication can be preserved for a longer period.

Appearance and packaging

Appearance

Pale yellow round film-coated tablet

Package unit

300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.